Unknown

Dataset Information

Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression.


ABSTRACT:

Background

Studies reporting collective and comprehensive data on plaque regression of different lipid-lowering therapies (LLTs) are limited.

Objectives

We evaluated plaque regression of LLTs based on multiple markers and performed subgroup analyses based on LLT type and post-treatment LDL-C levels.

Methods

A literature search was performed to identify studies assessing plaque regression from LLTs. The following LLTs groups were included: High-intensity statin (HIS), HIS+ eicosapentaenoic acid (EPA), HIS + ezetimibe, Low-intensity statin (LIS), LIS + EPA, LIS + Ezetimibe, and PCSK9 inhibitors. Our primary outcomes were change in percent atheroma volume (PAV). Secondary outcomes included mean differences in total atheroma volume (TAV), lumen, plaque, and vessel volumes

SUBMITTER: Rivera FB 

PROVIDER: S-EPMC10966153 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature